Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression.

Seokwoo ParkJung Pyo LeeDong Ki KimYon Su KimChun Soo Lim

Published in: PloS one (2022)

Allopurinol demonstrated attenuation of chronic kidney disease progression and prevention of hypouricemia, compared to febuxostat. Because the treatment can be renoprotective, further studies on its effects on chronic kidney disease are required.

Keyphrases

chronic kidney disease
end stage renal disease
combination therapy
peritoneal dialysis